Press Releases
HUMIRA HUBRIS: AbbVie Exec Brags about Scam to Keep Drug Prices High
WASHINGTON, DC –– On Wednesday, Bill Chase, CFO of the drug giant AbbVie, bragged to investors, “You’ve seen us execute very nicely with our legal strategy and the settlements around the U.S. events to delay the onset of [loss of Humira’s exclusivity] into the 2022-2023 time period,” Axios reported. In response, Patients For Affordable Drugs […]